Multidisciplinary Search
Multidisciplinary Multidisciplinary
Most Read Articles
Managing cystic fibrosis in primary care
Yesterday

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

LVADs reverse pulmonary hypertension secondary to left heart disease
Tristan Manalac, 15 May 2019
Left ventricular assist devices (LVADs) can reverse pulmonary hypertension secondary to left heart disease regardless of baseline pulmonary vascular resistance, according to a new study.
Fish, omega-3 fatty acid intake not associated with hypertension
Yesterday
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
Empagliflozin protects against CV risk factors in type 2 diabetes
6 days ago
Empagliflozin treatment in patients with type 2 diabetes mellitus exerts beneficial effects on cardiovascular (CV) risk factors, including blood pressure and uric acid, according to a systematic review and meta-analysis.

Podcast: Dr Brigette Ma talks about the current biomarkers for immuno-oncology

05 Dec 2018
Podcast: Dr Brigette Ma talks about the current biomarkers for immuno-oncology
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Managing cystic fibrosis in primary care
Yesterday

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

LVADs reverse pulmonary hypertension secondary to left heart disease
Tristan Manalac, 15 May 2019
Left ventricular assist devices (LVADs) can reverse pulmonary hypertension secondary to left heart disease regardless of baseline pulmonary vascular resistance, according to a new study.
Fish, omega-3 fatty acid intake not associated with hypertension
Yesterday
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
Empagliflozin protects against CV risk factors in type 2 diabetes
6 days ago
Empagliflozin treatment in patients with type 2 diabetes mellitus exerts beneficial effects on cardiovascular (CV) risk factors, including blood pressure and uric acid, according to a systematic review and meta-analysis.